IBB

Featured

Moderna Vaccine Optimism Could Drive Biotech ETFs

By Ian YoungAugust 26, 2020

Featured

Biotech ETFs Stumble Amid WHO Outlook On Vaccine

By Ian YoungAugust 21, 2020

Leveraged & Inverse Channel

Biotech Has Been in a Steady Uptrend Even Through Covid-19

By Ben HernandezAugust 20, 2020

Featured

U.S. Rejects Help From Russia In Race For Viable Vaccine

By Ian YoungAugust 17, 2020

Thematic Investing Channel

An Aging Population Could Help Boost Economy and this ETF

By Ben HernandezAugust 7, 2020

ETF Building Blocks Channel

Betting on Biotech With Utility Beyond Covid-19

By Tom LydonJuly 31, 2020

Nasdaq Portfolio Solutions Channel

Thematic Tech ETFs to Access Innovative Growth Ideas

By Max ChenJuly 30, 2020

Nasdaq Portfolio Solutions Channel

Thematic Tech in the New Normal

By Max ChenJuly 29, 2020

Featured

Biotech ETFs To Explore As Race For Covid-19 Vaccine Heats Up

By Ian YoungJuly 22, 2020

Tactical Allocation Channel

Big Biotech Stands Tall Amid Race for Virus Vaccine

By Tom LydonJuly 17, 2020

Featured

Moderna Study Sends Biotech ETFs And Stock Futures Surging

By Ian YoungJuly 14, 2020

Featured

Stock ETFs Build On Friday Gains, Ignoring Florida Virus Spike

By Ian YoungJuly 13, 2020

Featured

Stock ETFs Rally In Mixed Trade Amid Vaccine Developments

By Ian YoungJuly 10, 2020

Innovative ETFs Channel

Biotech ETFs Rally as ‘Operation Warp Speed’ Fuels Covid-19 Research

By Max ChenJuly 7, 2020

Featured

Biotech ETFs Gain Amid Vaccine Optimism

By Ian YoungJuly 1, 2020

Featured

Could Gilead News Be Good For Biotech ETFs?

By Ian YoungJune 24, 2020

ETF Building Blocks Channel

Biotech ETF Doesn’t Need Coronavirus Vaccines to Soar

By Tom LydonJune 2, 2020

Disruptive Technology Channel

This Is NOT 2008 All Over Again

By Special To ETF TrendsMay 23, 2020